23 min listen
LEAVO Trial - Comparison of Anti-VEGF drugs for Macular Edema Secondary to CRVO- Dr. Philip Hykin.
LEAVO Trial - Comparison of Anti-VEGF drugs for Macular Edema Secondary to CRVO- Dr. Philip Hykin.
ratings:
Length:
26 minutes
Released:
Feb 27, 2020
Format:
Podcast episode
Description
Dr. Philip Hykin discusses the LEAVO trial which was a large prospective trial comparing the efficacy of three main anti-VEGF intravitreal injections (bevacizumab, ranibizumab and aflibercept) for treating macular edema secondary to Central Retinal Vein Occlusion. The discussed article: Clinical Effectiveness of Intravitreal Therapy With Ranibizumab vs Aflibercept vs Bevacizumab for Macular Edema Secondary to Central Retinal Vein Occlusion: A Randomized Clinical Trial. Hykin P, Prevost AT, Vasconcelos JC, Murphy C, Kelly J, Ramu J, Hounsome B, Yang Y, Harding SP, Lotery A, Chakravarthy U, Sivaprasad S; LEAVO Study Group. JAMA Ophthalmol. 2019 Aug 29. doi:10.1001/jamaophthalmol.2019.3305.
Released:
Feb 27, 2020
Format:
Podcast episode
Titles in the series (77)
E7-Long Term Outcomes of 27-G Vitrectomy- Dr. Ali Khan: Dr. M. Ali Khan describes his article on the long term outcomes of 27-gauge vitrectomy for 390 eyes. Full reference of the articles is: Khan, M. A., Kuley, A., Riemann, C. D., Berrocal, M. H., Lakhanpal, R. R., Hsu, J., . . . Regillo, C. D. (2017).... by The Retina Channel Podcast